NO20060416L - New use I - Google Patents
New use IInfo
- Publication number
- NO20060416L NO20060416L NO20060416A NO20060416A NO20060416L NO 20060416 L NO20060416 L NO 20060416L NO 20060416 A NO20060416 A NO 20060416A NO 20060416 A NO20060416 A NO 20060416A NO 20060416 L NO20060416 L NO 20060416L
- Authority
- NO
- Norway
- Prior art keywords
- promotion
- inhibitor
- wound healing
- new use
- had1
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A61K31/426—1,3-Thiazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Diabetes (AREA)
- Epidemiology (AREA)
- Endocrinology (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Emergency Medicine (AREA)
- Dermatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Steroid Compounds (AREA)
- Thiazole And Isothizaole Compounds (AREA)
Abstract
Metode for promotering av sårheling, innbefattende administrasjon til et pattedyr, inkludert menneske, som har behov for slik promotering, av en effektiv mengde av en inhibitor av 11-(-hydroksysteroid dehydrogenase type I, hvor nevnte 11(-HAD1-inhibitor har formelen (I): hvor T, B, X, Y, R1 og R2 er som definert i beskrivelse og krav. Disse forbindelsene kan også anvendes i fremstillingen av et medikament for promotorering av sårheling.A method of promoting wound healing, including administration to a mammal, including human, in need of such promotion, of an effective amount of an inhibitor of 11 - (- hydroxysteroid dehydrogenase type I, wherein said 11 (-HAD1 inhibitor has the formula ( I): wherein T, B, X, Y, R 1 and R 2 are as defined in the description and claims, these compounds can also be used in the preparation of a medicament for the promotion of wound healing.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE0301882A SE0301882D0 (en) | 2003-06-25 | 2003-06-25 | New use I |
PCT/SE2004/000996 WO2004112784A1 (en) | 2003-06-25 | 2004-06-21 | New use i |
Publications (1)
Publication Number | Publication Date |
---|---|
NO20060416L true NO20060416L (en) | 2006-03-24 |
Family
ID=27656617
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO20060416A NO20060416L (en) | 2003-06-25 | 2006-01-25 | New use I |
Country Status (9)
Country | Link |
---|---|
EP (1) | EP1638553A1 (en) |
JP (1) | JP2007521264A (en) |
KR (1) | KR20060023570A (en) |
CN (1) | CN1812784A (en) |
AU (1) | AU2004249099A1 (en) |
CA (1) | CA2529406A1 (en) |
NO (1) | NO20060416L (en) |
SE (1) | SE0301882D0 (en) |
WO (1) | WO2004112784A1 (en) |
Families Citing this family (36)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ATE417837T1 (en) | 2004-05-24 | 2009-01-15 | Amgen Inc | INHIBITORS OF 11-BETA-HYDROXYSTEROID DEHYDROGENASE TYPE 1 |
US8686011B2 (en) | 2004-05-24 | 2014-04-01 | Amgen Inc. | Inhibitors of 11-β-hydroxy steroid dehydrogenase type 1 |
GB0506133D0 (en) * | 2005-03-24 | 2005-05-04 | Sterix Ltd | Compound |
JP5140577B2 (en) | 2005-03-31 | 2013-02-06 | タケダ カリフォルニア インコーポレイテッド | Hydroxysteroid dehydrogenase inhibitor |
US7622492B2 (en) | 2005-08-31 | 2009-11-24 | Hoffmann-La Roche Inc. | Pyrazolones as inhibitors of 11β-hydroxysteroid dehydrogenase |
AU2006316867A1 (en) | 2005-11-22 | 2007-05-31 | Amgen Inc. | Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1 |
BRPI0715160A2 (en) | 2006-08-08 | 2013-06-11 | Sanofi Aventis | arylamimoaryl-alkyl-substituted imidazolidine-2,4-diones, process for preparing them, drugs comprising these compounds, and their use |
JP5098011B2 (en) * | 2006-11-20 | 2012-12-12 | 国立大学法人山口大学 | Wound healing promoter |
DE102007005045B4 (en) | 2007-01-26 | 2008-12-18 | Sanofi-Aventis | Phenothiazine derivatives, process for their preparation and their use as medicines |
ES2523196T3 (en) * | 2007-07-13 | 2014-11-21 | Icagen, Inc. | Sodium Channel Inhibitors |
EP2025674A1 (en) | 2007-08-15 | 2009-02-18 | sanofi-aventis | Substituted tetra hydro naphthalines, method for their manufacture and their use as drugs |
WO2010003624A2 (en) | 2008-07-09 | 2010-01-14 | Sanofi-Aventis | Heterocyclic compounds, processes for their preparation, medicaments comprising these compounds, and the use thereof |
WO2010068601A1 (en) | 2008-12-08 | 2010-06-17 | Sanofi-Aventis | A crystalline heteroaromatic fluoroglycoside hydrate, processes for making, methods of use and pharmaceutical compositions thereof |
EP2470552B1 (en) | 2009-08-26 | 2013-11-13 | Sanofi | Novel crystalline heteroaromatic fluoroglycoside hydrates, pharmaceuticals comprising these compounds and their use |
WO2011107494A1 (en) | 2010-03-03 | 2011-09-09 | Sanofi | Novel aromatic glycoside derivatives, medicaments containing said compounds, and the use thereof |
EP2582709B1 (en) | 2010-06-18 | 2018-01-24 | Sanofi | Azolopyridin-3-one derivatives as inhibitors of lipases and phospholipases |
US8530413B2 (en) | 2010-06-21 | 2013-09-10 | Sanofi | Heterocyclically substituted methoxyphenyl derivatives with an oxo group, processes for preparation thereof and use thereof as medicaments |
TW201215388A (en) | 2010-07-05 | 2012-04-16 | Sanofi Sa | (2-aryloxyacetylamino)phenylpropionic acid derivatives, processes for preparation thereof and use thereof as medicaments |
TW201215387A (en) | 2010-07-05 | 2012-04-16 | Sanofi Aventis | Spirocyclically substituted 1,3-propane dioxide derivatives, processes for preparation thereof and use thereof as a medicament |
TW201221505A (en) | 2010-07-05 | 2012-06-01 | Sanofi Sa | Aryloxyalkylene-substituted hydroxyphenylhexynoic acids, process for preparation thereof and use thereof as a medicament |
US8828995B2 (en) | 2011-03-08 | 2014-09-09 | Sanofi | Branched oxathiazine derivatives, method for the production thereof, use thereof as medicine and drug containing said derivatives and use thereof |
US8871758B2 (en) | 2011-03-08 | 2014-10-28 | Sanofi | Tetrasubstituted oxathiazine derivatives, method for producing them, their use as medicine and drug containing said derivatives and the use thereof |
EP2683701B1 (en) | 2011-03-08 | 2014-12-24 | Sanofi | Oxathiazine derivatives substituted with benzyl or heteromethylene groups, method for their preparation, their usage as medicament, medicament containing same and its use |
EP2683698B1 (en) | 2011-03-08 | 2017-10-04 | Sanofi | Benzyl-oxathiazine derivates substituted with adamantane or noradamantane, medicaments containing said compounds and use thereof |
US8828994B2 (en) | 2011-03-08 | 2014-09-09 | Sanofi | Di- and tri-substituted oxathiazine derivatives, method for the production thereof, use thereof as medicine and drug containing said derivatives and use thereof |
WO2012120052A1 (en) | 2011-03-08 | 2012-09-13 | Sanofi | Oxathiazine derivatives substituted with carbocycles or heterocycles, method for producing same, drugs containing said compounds, and use thereof |
EP2683702B1 (en) | 2011-03-08 | 2014-12-24 | Sanofi | New substituted phenyl oxathiazine derivatives, method for their manufacture, medicines containing these compounds and their application |
WO2012120055A1 (en) | 2011-03-08 | 2012-09-13 | Sanofi | Di- and tri-substituted oxathiazine derivates, method for the production thereof, use thereof as medicine and drug containing said derivatives and use thereof |
WO2012120057A1 (en) | 2011-03-08 | 2012-09-13 | Sanofi | Novel substituted phenyl-oxathiazine derivatives, method for producing them, drugs containing said compounds and the use thereof |
WO2013037390A1 (en) | 2011-09-12 | 2013-03-21 | Sanofi | 6-(4-hydroxy-phenyl)-3-styryl-1h-pyrazolo[3,4-b]pyridine-4-carboxylic acid amide derivatives as kinase inhibitors |
WO2013045413A1 (en) | 2011-09-27 | 2013-04-04 | Sanofi | 6-(4-hydroxy-phenyl)-3-alkyl-1h-pyrazolo[3,4-b]pyridine-4-carboxylic acid amide derivatives as kinase inhibitors |
CN103204824B (en) * | 2012-01-12 | 2015-04-08 | 清华大学深圳研究生院 | 2-aminothiazole-4-amide derivative, its preparation method and application |
TW201512171A (en) | 2013-04-19 | 2015-04-01 | Pfizer Ltd | Chemical compounds |
CN105061288B (en) * | 2015-08-07 | 2017-09-15 | 武汉华素康生物科技有限公司 | Compound and its preparation method and application |
EP3235813A1 (en) | 2016-04-19 | 2017-10-25 | Cidqo 2012, S.L. | Aza-tetra-cyclo derivatives |
CN118340765B (en) * | 2024-04-30 | 2024-08-23 | 广州市朝利良生物科技有限公司 | Application of benzamide compound in preparation of wound healing promoting medicine |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
PH10639A (en) * | 1967-07-17 | 1977-07-22 | Research Corp | Method of treatment and composition containing silver sulfadiazine |
TR199701096T1 (en) * | 1995-04-04 | 1998-02-21 | Texas Biotechnology Corporation | Tienil-, Furil-, Pyrrolil- ve Bifenils�lfonamidler ve Bunlar�n Endotelin Etkinli�ini D�zenleyen T�revleri. |
ATE229949T1 (en) * | 1996-10-16 | 2003-01-15 | American Cyanamid Co | PRODUCTION AND USE OF ORTHO-SULFONAMIDO-HETEROARYLHYDROXAMIC ACIDS AS MATRIX METALLOPROTEINASE AND TACE INHIBITORS |
SE0001899D0 (en) * | 2000-05-22 | 2000-05-22 | Pharmacia & Upjohn Ab | New compounds |
-
2003
- 2003-06-25 SE SE0301882A patent/SE0301882D0/en unknown
-
2004
- 2004-06-21 AU AU2004249099A patent/AU2004249099A1/en not_active Abandoned
- 2004-06-21 EP EP04749034A patent/EP1638553A1/en not_active Withdrawn
- 2004-06-21 WO PCT/SE2004/000996 patent/WO2004112784A1/en not_active Application Discontinuation
- 2004-06-21 CA CA002529406A patent/CA2529406A1/en not_active Abandoned
- 2004-06-21 JP JP2006517048A patent/JP2007521264A/en active Pending
- 2004-06-21 CN CNA2004800177434A patent/CN1812784A/en active Pending
- 2004-06-21 KR KR1020057024626A patent/KR20060023570A/en not_active Application Discontinuation
-
2006
- 2006-01-25 NO NO20060416A patent/NO20060416L/en not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
KR20060023570A (en) | 2006-03-14 |
JP2007521264A (en) | 2007-08-02 |
CN1812784A (en) | 2006-08-02 |
AU2004249099A1 (en) | 2004-12-29 |
SE0301882D0 (en) | 2003-06-25 |
CA2529406A1 (en) | 2004-12-29 |
WO2004112784A1 (en) | 2004-12-29 |
EP1638553A1 (en) | 2006-03-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO20060416L (en) | New use I | |
SE0301886D0 (en) | New use V | |
SE0301888D0 (en) | New use VII | |
TR200103493T2 (en) | Metalloprotease inhibitors | |
SE0101387D0 (en) | Novel compounds | |
NO972538L (en) | New sulfonamides | |
NO20064347L (en) | Substituted 1,2,3,4-tetrahydroisoquinoline derivatives | |
ATE469136T1 (en) | INHIBITORS OF 11-BETA-HYDROXYSTEROID DEHYDROGENASE TYPE 1 | |
ATE344029T1 (en) | TREATING TYPE II DIABETES WITH DIPEPTIDYL PEPTIDASE IV INHIBITORS | |
NO20051600L (en) | 1,4-disubstituted piperidine derivatives and their use as 11-betaHSD1 inhibitors | |
RS52942B (en) | Treatment of type 2 diabetes with a combination of dpiv inhibitor and metformin or thiazolidinedione | |
SG166791A1 (en) | Novel macrocyclic inhibitors of hepatitis c virus replication | |
EA200501268A1 (en) | HIV-Inhibiting 1,2,4-TRIAZINS | |
DK1411932T3 (en) | Combination therapy with substituted oxazolidinones | |
WO2005034952A3 (en) | Isoxazole and isothiazole compounds useful in the treatment of inflammation | |
IS2696B (en) | Substituted 2-aminotetraline for the treatment of depression | |
NO20065904L (en) | Therapeutic compounds | |
NO20083005L (en) | Use of benzofused heterocyclic sulfamide derivatives for the treatment of pain | |
MY143568A (en) | 11b-hsd1 inhibitors for the treatment of diabetes | |
NO20050667L (en) | N-substituted-1H-indole-5-propionic acid compounds as PPAR agonists useful for the treatment of diabetes | |
EA200201276A1 (en) | ARYLMETYLAMINE DERIVATIVES FOR USE AS TRIPTASE INHIBITORS | |
SE0203304D0 (en) | Novel Coumpounds | |
ATE333901T1 (en) | PHARMACEUTICAL COMPOSITION OF A BIGUANINE (METFORMIN) AND ARGININE | |
HUP0200152A2 (en) | Utilization of inhibitors of the kqt1 channel in order to produce a medicament for treating diseases which are caused by parasitic helminths and ectoparasites | |
SE0004101D0 (en) | New use |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC2A | Withdrawal, rejection or dismissal of laid open patent application |